Search

Your search keyword '"Pandey UB"' showing total 84 results

Search Constraints

Start Over You searched for: Author "Pandey UB" Remove constraint Author: "Pandey UB"
84 results on '"Pandey UB"'

Search Results

2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

3. Measurement of the bottom-strange meson mixing phase in the full CDF data set

4. Guidelines for the use and interpretation of assays for monitoring autophagy.

6. HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models.

7. Function and dysfunction of GEMIN5: understanding a novel neurodevelopmental disorder.

8. Mutations of GEMIN5 are associated with coenzyme Q 10 deficiency: long-term follow-up after treatment.

9. HuD (ELAVL4) gain-of-function impairs neuromuscular junctions and induces apoptosis in in vitro and in vivo models of amyotrophic lateral sclerosis.

10. MATR3 pathogenic variants differentially impair its cryptic splicing repression function.

11. CLIP-Seq analysis enables the design of protective ribosomal RNA bait oligonucleotides against C9ORF72 ALS/FTD poly-GR pathophysiology.

12. Drosha-dependent microRNAs modulate FUS-mediated neurodegeneration in vivo.

13. SMN regulates GEMIN5 expression and acts as a modifier of GEMIN5-mediated neurodegeneration.

14. Editorial: Drosophila as a model to study neurodegenerative diseases.

15. Loss of function of the ALS-associated NEK1 kinase disrupts microtubule homeostasis and nuclear import.

16. C9orf72 poly(PR) mediated neurodegeneration is associated with nucleolar stress.

17. NgR1 binding to reovirus reveals an unusual bivalent interaction and a new viral attachment protein.

18. Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2.

19. LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice.

20. Antagonistic effect of cyclin-dependent kinases and a calcium-dependent phosphatase on polyglutamine-expanded androgen receptor toxic gain of function.

21. WNK kinases sense molecular crowding and rescue cell volume via phase separation.

22. Further delineation of GEMIN4 related neurodevelopmental disorder with microcephaly, cataract, and renal abnormalities syndrome.

23. Pathogenic variants of Valosin-containing protein induce lysosomal damage and transcriptional activation of autophagy regulators in neuronal cells.

24. Skeletal Muscle Pathogenesis in Polyglutamine Diseases.

25. NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility.

26. Functional and structural deficiencies of Gemin5 variants associated with neurological disorders.

28. Autosomal Recessive Cerebellar Atrophy and Spastic Ataxia in Patients With Pathogenic Biallelic Variants in GEMIN5 .

29. DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner.

30. Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway.

31. Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology.

32. Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder.

33. Huntingtin-mediated axonal transport requires arginine methylation by PRMT6.

34. Impairment of the mitochondrial one-carbon metabolism enzyme SHMT2 causes a novel brain and heart developmental syndrome.

35. Optogenetic TDP-43 nucleation induces persistent insoluble species and progressive motor dysfunction in vivo.

36. RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3.

37. RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM.

38. Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in vivo.

39. Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity.

40. Insulin-like growth factor 1 signaling in motor neuron and polyglutamine diseases: From molecular pathogenesis to therapeutic perspectives.

41. Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism.

42. Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization.

43. FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy.

44. RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43.

45. Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo.

46. RNP-Granule Assembly via Ataxin-2 Disordered Domains Is Required for Long-Term Memory and Neurodegeneration.

47. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains.

48. Traumatic injury induces stress granule formation and enhances motor dysfunctions in ALS/FTD models.

49. Isogenic FUS-eGFP iPSC Reporter Lines Enable Quantification of FUS Stress Granule Pathology that Is Rescued by Drugs Inducing Autophagy.

50. Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS.

Catalog

Books, media, physical & digital resources